secwatch.observer — SEC 8-K summary
======================================

Issuer:     DiaMedica Therapeutics Inc. (DMAC)
CIK:        0001401040
Form:       8-K
Filed at:   2021-09-27T23:59:59+00:00
Accession:  0001437749-21-022654
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 3.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

DiaMedica raises $30M in private placement at $3.92/share for DM199 development
-------------------------------------------------------------------------------

- Gross proceeds of $30M from sale of 7,653,060 common shares at $3.92 each.
- Closing expected September 28, 2021; net proceeds to fund DM199 clinical development including ReMEDy2 trial.
- Ten accredited investors participate; shares unregistered but resale registration to be filed with SEC.
- Funds also allocated to working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/0001437749-21-022654-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1401040/000143774921022654/dmtp20210926_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-21-022654

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer